LEADER 00000cam  22000004a 4500 
001    ocm58533799 
003    OCoLC 
005    20110322090029.0 
008    050314s2006    flua     b    001 0 eng   
010      2005041802 
015    GBA4Z4364|2bnb 
016 7  101243790|2DNLM 
016 7  010980105|2Uk 
019    56465024 
020    0415288770|qhardcover 
020    0415288789|qpaperback 
020    9780415288781|qpaperback 
020    9780415288774|qhardcover 
035    (OCoLC)58533799 
035    (OCoLC)58533799|z(OCoLC)56465024 
040    DNLM/DLC|beng|cDLC|dNLM|dBAKER|dC#P|dUKM|dMUQ|dBTCTA|dUMM
       |dSTF|dYDXCP|dOCLCG|dIG#|dVGM|dDEBBG|dSTJ 
042    pcc 
049    STJP 
050 00 RS420|b.S64 2006 
060 00 2005 O-287 
060 10 QV 744|bS642 2006 
082 00 615/.7|222 
084    VC 6250|2rvk 
084    XI 1300|2rvk 
092    615.7|bS6426 
245 00 Smith and Williams' introduction to the principles of drug
       design and action /|cedited by H. John Smith. 
246 30 Introduction to the principles of drug design and action 
250    Fourth edition. 
264  1 Boca Raton :|bCRC Taylor & Francis,|c2006. 
300    xvi, 658 pages :|billustrations (some color) ;|c27 cm 
336    text|btxt|2rdacontent 
337    unmediated|bn|2rdamedia 
338    volume|bnc|2rdacarrier 
504    Includes bibliographical references and index. 
505 0  Procsses of drug handling by the body / Mark Gumbleton -- 
       The design of drug delivery systems / Ian W. Kellaway -- 
       Fundamental pharmacokinetics / Glyn Taylor -- 
       Intermolecular forces and molecular modeling / Robin H. 
       Davies -- Drug chirality and its pharmacological 
       consequences / Andrew J. Hutt -- Quantitative structure-
       activity relationships (QSAR) in drug design / John C. 
       Dearden and Mark T.D. Cronin -- Prodrugs / Andrew W. Lloyd
       -- From program sanction to clinical trials: a partial 
       view of the quest for arimidex, a potent, selective 
       inhibitor of aromatase / Philip N. Edwards -- Design of 
       enzyme inhibitors as drugs / Anjana Patel, H. John Smith, 
       and Torsten Steinmetzer -- Peptide drug design / David J. 
       Barlow -- Combinatorial chemistry: a tool for drug 
       discovery / Barrie Kellam -- Recombinant DNA technology: 
       monoclonal antibodies / Frederick J. Rowell -- The human 
       genome and its impact on drug discovery and therapy / 
       Frederick J. Rowell -- The chemotherapy of cancer / David 
       E. Thurston -- Neurotransmitters, agonists, and 
       antagonists / Robert D.E. Sewell ... [et al.] -- Design of
       antibacterial, antifungal, and antiviral agents / Claire 
       Simons and A. Denver Russell -- Pharmaceutical 
       applications of bioinorganic chemistry / David M. Taylor 
       and David R. Williams. 
650  0 Drugs|xDesign. 
650  0 Drugs|xStructure-activity relationships. 
650 12 Drug Design. 
650 22 Pharmacologic Actions. 
700 1  Smith, H. J.,|d1930- 
700 1  Williams, Hywel. 
856 42 |3Publisher description|uhttp://catdir.loc.gov/catdir/
       enhancements/fy0646/2005041802-d.html 
938    Baker & Taylor|bBKTY|c99.95|d.00|i0415288770|n0006272668
       |sactive 
938    YBP Library Services|bYANK|n100347940 
938    Ingram|bINGR|n9780415288774 
994    01|bSTJ